SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT

HALF-YEAR FINANCIAL

QUARTERLY INFORMATION

20F

AGM

INTERNAL CONTROL

ANNUAL INFO MEMO ART

   
   
   

PERMANENT INFORMATION

2018.08.14 | 07:00 | Permanent Information Releases / Appointments

English version HTML (w) Mail

NOVARTIS

 Novartis appoints Dr. Klaus Moosmayer as Chief Ethics Risk and Compliance Officer - HTML (w)

2018.08.14 | 07:00 | Permanent Information Releases / Appointments

German version HTML (w) Mail

NOVARTIS

 Novartis ernennt Dr. Klaus Moosmayer zum Chief Ethics, Risk and Compliance Officer - HTML (w)

2018.08.03 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

ROCHE

 PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington's disease - HTML (w)

2018.08.02 | 07:00 | Permanent Information Releases / Operations

English version HTML (w) Mail

GAM HOLDING

 GAM fund boards suspend dealing in unconstrained/absolute return bond funds - HTML (w)

+ More documents (2649)

Financial transactions

2018.07.31 | 07:00 | Public offerings / Statement of purchases / sales

English version HTML (w) Mail

ROCHE

 Roche Purchases Shares in Tender Offer for FMI - HTML (w)

2018.07.02 | 17:35 | Public offerings / Information note / Note in response

English version HTML (w) Mail

ROCHE

 Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash - HTML (w)

2018.05.15 | 06:45 | Public offerings / Statement of purchases / sales

English version HTML (w) Mail

NOVARTIS

 Novartis completes tender offer for all outstanding shares of AveXis, Inc. - HTML (w)

2018.04.17 | 07:00 | Public offerings / Press Releases during Offer Period

English version HTML (w) Mail

NOVARTIS

 Novartis tender offer for AveXis commences - HTML (w)

2018.02.01 | 22:05 | Public offerings / Press Releases during Offer Period

English version HTML (w) Mail

NOVARTIS

 Novartis completes subsequent offering period of the tender offer for Advanced Accelerator Applications S.A. - HTML (w)

+ More documents (35)